Arcus Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Mar 24 | SellUS$240,941 | Jennifer Jarrett | Individual | 13,449 | US$18.62 | |
29 Jan 24 | BuyUS$319,999,995 | Gilead Sciences, Inc. | Company | 15,238,095 | US$21.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 26,121 | 0.0283% |
Private Companies | 4,198,244 | 4.55% |
Individual Insiders | 5,729,223 | 6.2% |
Public Companies | 30,061,124 | 32.6% |
Institutions | 52,333,386 | 56.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
30,061,124 | US$539.6m | 0% | no data | |||
9,763,113 | US$175.2m | -1.39% | no data | |||
5,257,326 | US$94.4m | 9.73% | no data | |||
4,245,221 | US$76.2m | 47.2% | 0.7% | |||
4,180,791 | US$75.0m | -12.5% | no data | |||
3,731,279 | US$67.0m | 1,210% | no data | |||
3,433,870 | US$61.6m | 0% | no data | |||
3,055,056 | US$54.8m | -37.7% | no data | |||
1,950,452 | US$35.0m | 1.85% | 0.08% | |||
1,612,077 | US$28.9m | 0% | 29.73% | |||
1,602,200 | US$28.8m | 0% | 1.37% | |||
1,479,627 | US$26.6m | -8.74% | no data | |||
1,474,438 | US$26.5m | 22.8% | 0.01% | |||
1,427,920 | US$25.6m | 0.48% | no data | |||
1,260,782 | US$22.6m | 9.53% | 0.01% | |||
1,233,075 | US$22.1m | 5.21% | no data | |||
957,304 | US$17.2m | 0% | 0.64% | |||
869,790 | US$15.6m | 0% | 4.19% | |||
744,298 | US$13.4m | 8.65% | 0.02% | |||
556,571 | US$10.0m | 192% | no data | |||
511,850 | US$9.2m | 1.35% | no data | |||
507,443 | US$9.1m | 2.87% | no data | |||
501,433 | US$9.0m | -2.35% | no data | |||
467,163 | US$8.4m | 31.6% | 0.01% | |||
436,533 | US$7.8m | -20.3% | 0.26% |